On June 6th, the Lithuanian parliament passed a revised Tobacco and Related Products Control Law, with 112 MPs voting in favor, 5 voting against, and 6 abstentions. The amendment will undergo further review on June 20th.
The main originator of this revision, Vytautas Kernagis, stated that it aims to curb retailers from selling e-cigarettes and related accessories in ways to circumvent relevant bans. According to him, flavored cigarettes and e-liquids contain sugar or sweeteners to enhance the taste, and these ingredients can be detected through testing in Lithuanian laboratories.
Kernagis has stated that the ban on flavored e-cigarettes issued about a year ago has been disregarded by manufacturers. To prove this point, regulatory agencies have sent e-cigarettes to Denmark to undergo testing, which the distributors of these products are unhappy with after seeing the results.
At present, the regulation prohibits the supply of e-liquids containing vitamins or substances that are harmful to health. It is also prohibited to import cigarettes and e-liquids containing caffeine, taurine, and other stimulants, as well as the use of dyes in the e-liquids to prevent the release of harmful substances.
Reference: Seimas proposes even stricter limitations on sales of flavored e-cigarettes. The Lithuanian Seimas (Parliament) has put forward a proposal to tighten restrictions on the sale of electronic cigarettes with flavors.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
